Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00182403
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2005-09-13
Brief Title:
Fixed Dose Heparin Study
Sponsor:
McMaster University
Organization:
McMaster University
Study Overview
Official Title:
Fixed Dose Unfractionated Heparin for Initial Treatment of Venous Thromboembolism
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
FIDO was a multicentred randomized open-label trial that compared fixed-dose UFH with fixed-dose LMWH for initial treatment of VTE Patients were followed for 3 months during which they received warfarin target INR 20-30
Detailed Description:
The general objective was to simplify and reduce the cost of treatment of acute venous thromboembolism VTESpecific objectives were to compare the efficacy safety and cost effectiveness of unfractionated heparin UFH and low molecular weight heparin LMWH when each is administered subcutaneously sc twice daily in weight -adjusted fixed doses and to determine if the anticoagulant response anti-Factor Xa heparin levels APTT results influence efficacy and safety of UFH and LMWH independently of dose
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NA3640 | None | None | None |